Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ae [Adverse Effects]. Found 19 abstracts

Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ, Global AT. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. New England Journal of Medicine. 2007 May 31;356(22):2271-81.
Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. International Journal of Radiation Oncology, Biology, Physics. 2005 Jul 15;62(4):956-64.
Held-Warmkessel J. Managing three critical cancer complications. Nursing. 2005 Jan;35(1):58-63; quiz 63-4.
Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer. 2005 Jul;5(2):108-13.
Borghaei H, Schilder RJ. Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Seminars in Nuclear Medicine. 2004 Jan;34(1 Suppl 1):4-9.
Borghaei H, Wallace SG, Schilder RJ. Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma. Clinical Lymphoma. 2004 Oct;5 Suppl 1:S16-21.
Horwitz EM, Feigenberg SJ, Uzzo RG. The treatment of non-metastatic prostate cancer with external beam radiation therapy. Minerva Urologica e Nefrologica. 2004 Jun;56(2):173-88.
Feigenberg SJ, Wolk KL, Yang CH, Morris CG, Zlotecki RA. Celecoxib to decrease urinary retention associated with prostate brachytherapy. Brachytherapy. 2003 Jan;2(2):103-7.
Davey MP. Cancer treatments. Imatinib mesylate. Clinical Journal of Oncology Nursing. 2002 Mar;6(2):118-20.
Dell DD. Test your knowledge. Deep vein thrombosis in the patient with cancer. Clinical Journal of Oncology Nursing. 2002 Jan;6(1):43-6.
Movsas B, Hudes RS, Schol J, Millenson M, Rosvold E, Nicolaou N, Litwin S, Wang H, Keenan E, Curran WJ, Langer CJ. Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report. Clinical lung cancer. 2001 Jan;3(2):125-32.
Kedziera PL. Apothecary jar: oral transmucosal fentanyl citrate. ASPMN Pathways. 1998 Jan;7(2):11.
Fowble B. The integration of conservative surgery and radiation for stage I-II breast cancer with adjuvant systemic therapy. Breast Journal. 1997 Sep;3(5):284-91.
Freedman GM, Fowble BL, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Goldstein LJ. Postmastectomy radiation and adjuvant systemic therapy: outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing local-regional control. Breast Journal. 1997 Nov;3(6):337-44.
Dell DD, Kehoe C. Plasma cholinesterase deficiency. Journal of Perianesthesia Nursing. 1996 Oct;11(5):304-8.
Martin VR. On the horizon. Clinical review of docetaxel (TAXOTERE). Innovations in Breast Cancer Care. 1996 Oct;2(1):9-12.
Orleans CT, Resch N, Noll E, Keintz MK, Rimer BK, Brown TV, Snedden TM. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at "real-world" patch users. JAMA. 1994 Feb 23;271(8):601-7.
Ottery FD. Cancer cachexia: prevention, early diagnosis, and management [corrected] [published erratum appears in CANCER PRACT 1994 Jul-Aug;2(4):263]. Cancer Practice. 1994 Mar;2(2):123-31.
Rogers BB. Taxol: a promising new drug of the '90s. Oncology Nursing Forum. 1993 Nov;20(10):1483-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ae [Adverse Effects]

ae [Adverse Effects] dt [Drug Therapy] Male rt [Radiotherapy] Aged Female Antineoplastic Agents ad [Administration and Dosage] Middle Aged tu [Therapeutic Use] mt [Methods] Breast Neoplasms Adult Radiotherapy 0 (Antineoplastic Agents) Patient Education Prostatic Neoplasms di [Diagnosis] tu [Therapeutic use] et [Etiology] Treatment Outcome Middle Age mo [Mortality] ci [Chemically Induced] Radioimmunotherapy Brachytherapy Monoclonal Antibodies Karnofsky Performance Status sc [Secondary] ep [Epidemiology] Pennsylvania Yttrium Radioisotopes co [Complications] Non-Hodgkin Lymphoma pa [Pathology] 80 and over Aged Adjuvant Chemotherapy Local Neoplasm Recurrence Neoplasms Risk Factors Quality of Life pd [Pharmacodynamics] Survival Analysis Human Prognosis Survival Clinical Trials Lung Neoplasms Cancer Patients Smoking Cessation im [Immunology] Treatment Outcomes su [Surgery] Cancer Pain Research Instruments Disease Progression Foreign-Body Reaction Questionnaires Multivariate Analysis Gastrointestinal System Cancer Chemotherapy Clinical Assessment Tools Drug Approval aa [Analogs & Derivatives] 0 (Yttrium Radioisotopes) Non-US Gov't Research Support Surveys Succinylcholine Granulocyte Colony-Stimulating Factor Nicotine Dosage Forms Urinary Retention Proportional Hazards Models Drug Administration CD20 Antigens Leukopenia Incidence 0 (cci 779) Safety Counseling Self Directed Learning Drug Interactions Inappropriate ADH Syndrome Thrombocytopenia Nursing Diagnosis Paclitaxel Prospective Studies EC 2-7-1-37 (Protein Kinases) Heparin Non-Steroidal Anti-Inflammatory Agents 0 (ibritumomab tiuxetan) nu [Nursing] Myeloid Leukemia Radiotherapy Dosage Algorithms Brain Neoplasms Oral Administration Outpatients Adenocarcinoma Sulfonamides Retrospective Studies Kidney Neoplasms Drug Hypersensitivity Fisher's Exact Test 0 (Interferon-alpha) 80 and Over Aged Protein Kinase Inhibitors de [Drug Effects] pc [Prevention & Control] Antineoplastic Combined Chemotherapy Protocols tu [Therapeutic Use] Postoperative Complications Penile Erection Continuing (Credit) Education 53123-88-9 (Sirolimus) Carboplatin Non-US Gov't Support Hematologic Diseases Perianesthesia Nursing th [Therapy] Oncologic Nursing Philadelphia Interferon-alpha Nursing Interventions Health Status Conformal Radiotherapy Oncologic Care Telephone Funding Source Transcutaneous Administration 0 (Protein Kinase Inhibitors) Second Primary Neoplasms Neoplasm Staging NIH Research Support-Extramural Survival Rate Heart Cholinesterases Impotence 0 (Iodine Radioisotopes) pc [Prevention and Control] Urinary Incontinence Inpatients Kaplan-Meier Estimator Drug Administration Schedule Iodine Radioisotopes Megestrol Combined Modality Therapy Neoplasm Metastasis Radiation Dosage
Last updated on Wednesday, February 05, 2020